NestInvest 2 ApS
Private limited companyCVR 39807114København NVActive
NestInvest 2 ApS is a private limited company, based in København NV, active in wholesale of pharmaceutical goods and nursing supplies, founded in 2018. Net profit rose 9% from 2024 to 2025, ending at DKK 1m. Profit has grown three years in a row.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit rose 9% (2024 → 2025), to DKK 1.3m.
- Net profit rose 9% (2024 → 2025), to DKK 1m.
- Equity rose 9% (2024 → 2025), to DKK 1.7m.
Registrations, last 24 months
- 14/05/2025: Moved to Hejrevej 39, 1, 2400 København NV
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2020–2025 · amounts in DKK thousandEquity and net profit
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | not stated | – |
| Gross profit | 33 | 2,237 | 3,708 | 928 | 1,225 | 1,329 | +8.5% |
| Operating profit (EBIT) | 23 | 148 | 525 | 895 | 1,195 | 1,299 | +8.7% |
| Profit before tax | 17 | 121 | 479 | 867 | 1,214 | 1,323 | +9% |
| Net profit | 13 | 95 | 374 | 676 | 947 | 1,032 | +9% |
| Total assets | 426 | 2,446 | 1,656 | 1,762 | 2,055 | 2,028 | −1.3% |
| Equity | 58 | 152 | 526 | 1,202 | 1,549 | 1,681 | +8.5% |
| Liabilities | 361 | 2,283 | 1,117 | 544 | 487 | 326 | −33.1% |
| Cash and cash equivalents | 67 | 2,050 | 530 | 397 | 655 | 538 | −17.9% |
| Average number of employees | – | 1 | 2 | 0 | 0 | 0 | – |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresProfit for five years in a row
Net result has been positive in 2021–2025.
How is this calculated?
Net result is positive in the five latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 26/06/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 26/06/2025 | The company | PDFXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 16/06/2024 | The company | PDFXBRL |
| 2022 | 01/01/2022 – 31/12/2022 | 06/07/2023 | The company | PDFXBRL |
| 2021 | 01/01/2021 – 31/12/2021 | 29/06/2022 | The company | PDFXBRL |
| 2020 | 01/01/2020 – 31/12/2020 | 30/06/2021 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
232 companies in the databaseComparison with the other companies in wholesale of pharmaceutical goods and nursing supplies based on the latest financial year.
Industry median: gross profit DKK 11.2m, net profit DKK 1.8m, equity DKK 9.6m, 9 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 39,317of 69,742 Better than 44% | No. 26,638of 69,964 Better than 62% |
| Same industry and fewer than 20 employees150 companies in the comparison | No. 116of 150 Better than 23% | No. 99of 150 Better than 34% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | No. 20,787of 33,588 Better than 38% | No. 11,926of 33,687 Better than 65% |
| All companies of type ApS66,508 companies in the comparison | No. 37,914of 66,379 Better than 43% | No. 22,662of 66,505 Better than 66% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Wholesale of pharmaceutical goods and nursing supplies- NestInvest 2 ApSDKK 1.3m
- Ambu A/SDKK 3.6bn
- Stada Nordic ApSDKK 687m
- NestInvest 2 ApSDKK 1m
- Ambu A/SDKK 609m
- Stada Nordic ApSDKK 54.6m
- NestInvest 2 ApSDKK 1.7m
- Ambu A/SDKK 6bn
- Stada Nordic ApSDKK 346.3m
- NestInvest 2 ApS2
- Ambu A/S619
- Stada Nordic ApS51
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership RegisterManagement
2 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Mads Renlef Henningsen | CEO | 23/08/2018 |
| Lars Mark Poulsen | Director | 23/08/2018 |
- Founders
- Mads Renlef Henningsen, Lars Mark Poulsen
Signing rule: Virksomheden tegnes af 1 direktør
Address and production units
1 active production unitsHejrevej 39
2400 København NV
| Production unit | Address | Employees | P number |
|---|---|---|---|
| NestInvest 2 ApS | Hejrevej 39, 1, 2400 København NV | 2 | 1023891286 |
Purpose
Selskabets formål er at drive handels-, rådgivnings- og konsulentvirksomhed inden for den farmaceutiske og medikotekniske industri
The purpose is quoted from the register in Danish.
Changes year by year
11 registered events20261 changeaccounts 1
- AccountsAnnual report for 2025 published
20252 changesaccounts 1 · address 1
- AccountsAnnual report for 2024 published
- AddressMoved to Hejrevej 39, 1, 2400 København NV
20241 changeaccounts 1
- AccountsAnnual report for 2023 published
20231 changeaccounts 1
- AccountsAnnual report for 2022 published
20221 changeaccounts 1
- AccountsAnnual report for 2021 published
20211 changeaccounts 1
- AccountsAnnual report for 2020 published
20184 changesfounded 1 · management 2 · ownership 1
- FoundedRegistered as NestInvest 2 ApS
- ManagementMads Renlef Henningsen appointed ceo
- ManagementLars Mark Poulsen appointed director
- OwnershipNest Egg ApS registered as owner (100%)
Related companies
Same industry in København
- Nomeco A/S939 employees
- Abacus Medicine A/S388 employees
- Novo Nordisk Denmark A/S300 employees
- Msd Danmark ApS132 employees
- Astrazeneca A/S122 employees
- Sandoz A/S118 employees
Same people in management
- Macure Pharma ApSvia Lars Mark Poulsen
- LAMA Management ApSvia Lars Mark Poulsen
- Pharmanovia A/Svia Mads Renlef Henningsen
- Nest Egg ApSvia Lars Mark Poulsen
Largest in the industry
- Ambu A/SDKK 3.6bn
- Stada Nordic ApSDKK 687m
- Nomeco A/SDKK 683m
- Orifarm Supply A/SDKK 538.5m
- Novo Nordisk Denmark A/SDKK 497.5m
- Sandoz A/SDKK 260.2m
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.